Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability

被引:11
作者
Clark, Charles G. [1 ]
Rossi, Karen A. [1 ]
Corte, James R. [1 ]
Fang, Tianan [1 ]
Smallheer, Joanne M. [1 ]
De Lucca, Indawati [1 ]
Nirschl, David S. [1 ]
Orwat, Michael J. [1 ]
Pinto, Donald J. P. [1 ]
Hu, Zilun [1 ]
Wang, Yufeng [1 ]
Yang, Wu [1 ]
Jeon, Yoon [1 ]
Ewing, William R. [1 ]
Myers, Joseph E., Jr. [1 ]
Sheriff, Steven [1 ]
Lou, Zhen [1 ]
Bozarth, Jeffrey M. [1 ]
Wu, Yiming [1 ]
Rendina, Alan [1 ]
Harper, Timothy [1 ]
Zheng, Joanna [1 ]
Xin, Baomin [1 ]
Xiang, Qian [1 ]
Luettgen, Joseph M. [1 ]
Seiffert, Dietmar A. [1 ]
Wexler, Ruth R. [1 ]
Lam, Patrick Y. S. [1 ]
机构
[1] Bristol Myers Squibb Co, POB 4000, Princeton, NJ 08543 USA
关键词
Factor XIa inhibitors; FXIa; Activated partial thromboplastin time; aPTT; Thrombosis; Anticoagulant; Bioavailability; COAGULATION-FACTOR XIA; SMALL-MOLECULE; BLEEDING-TIME; DISEASE; POTENT;
D O I
10.1016/j.bmcl.2019.08.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This manuscript describes the discovery of a series of macrocyclic inhibitors of FXIa with oral bioavailability. Assisted by structure based drug design and ligand bound X-ray crystal structures, the group linking the P1 moiety to the macrocyclic core was modified with the goal of reducing H-bond donors to improve pharmacokinetic performance versus 9. This effort resulted in the discovery of several cyclic P1 linkers, exemplified by 10, that are constrained mimics of the bioactive conformation displayed by the acrylamide linker of 9. These cyclic P1 linkers demonstrated enhanced bioavailability and improved potency.
引用
收藏
页数:7
相关论文
共 18 条
[11]  
IRIFUNE S, 1988, SYNTHESIS-STUTTGART, P366
[12]   Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties [J].
Pinto, Donald J. P. ;
Smallheer, Joanne M. ;
Corte, James R. ;
Austin, Erin J. D. ;
Wang, Cailan ;
Fang, Tianan ;
Smith, Leon M., II ;
Rossi, Karen A. ;
Rendina, Alan R. ;
Bozarth, Jeffrey M. ;
Zhang, Ge ;
Wei, Anzhi ;
Ramamurthy, Vidhyashankar ;
Sheriff, Steven ;
Myers, Joseph E., Jr. ;
Morin, Paul E. ;
Luettgen, Joseph M. ;
Seiffert, Dietmar A. ;
Quan, Mimi L. ;
Wexler, Ruth R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) :1635-1642
[13]   Thrombosis: a major contributor to the global disease burden [J].
Raskob, G. E. ;
Angchaisuksiri, P. ;
Blanco, A. N. ;
Buller, H. ;
Gallus, A. ;
Hunt, B. J. ;
Hylek, E. M. ;
Kakkar, A. ;
Konstantinides, S. V. ;
McCumber, M. ;
Ozaki, Y. ;
Wendelboe, A. ;
Weitz, J. I. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (10) :1580-1590
[14]   Molecular properties that influence the oral bioavailability of drug candidates [J].
Veber, DF ;
Johnson, SR ;
Cheng, HY ;
Smith, BR ;
Ward, KW ;
Kopple, KD .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2615-2623
[15]   Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 [J].
Wang, Haidong ;
Naghavi, Mohsen ;
Allen, Christine ;
Barber, Ryan M. ;
Bhutta, Zulfiqar A. ;
Carter, Austin ;
Casey, Daniel C. ;
Charlson, Fiona J. ;
Chen, Alan Zian ;
Coates, Matthew M. ;
Coggeshall, Megan ;
Dandona, Lalit ;
Dicker, Daniel J. ;
Erskine, Holly E. ;
Ferrari, Alize J. ;
Fitzmaurice, Christina ;
Foreman, Kyle ;
Forouzanfar, Mohammad H. ;
Fraser, Maya S. ;
Pullman, Nancy ;
Gething, Peter W. ;
Goldberg, Ellen M. ;
Graetz, Nicholas ;
Haagsma, Juanita A. ;
Hay, Simon I. ;
Huynh, Chantal ;
Johnson, Catherine ;
Kassebaum, Nicholas J. ;
Kinfu, Yohannes ;
Kulikoff, Xie Rachel ;
Kutz, Michael ;
Kyu, Hmwe H. ;
Larson, Heidi J. ;
Leung, Janni ;
Liang, Xiaofeng ;
Lim, Stephen S. ;
Lind, Margaret ;
Lozano, Rafael ;
Marquez, Neal ;
Mensah, George A. ;
Mikesell, Joe ;
Mokdad, Ali H. ;
Mooney, Meghan D. ;
Nguyen, Grant ;
Nsoesie, Elaine ;
Pigott, David M. ;
Pinho, Christine ;
Roth, Gregory A. ;
Salomon, Joshua A. ;
Sandar, Logan .
LANCET, 2016, 388 (10053) :1459-1544
[16]   In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa [J].
Wong, Pancras C. ;
Quan, Mimi L. ;
Watson, Carol A. ;
Crain, Earl J. ;
Harpel, Mark R. ;
Rendina, Alan R. ;
Luettgen, Joseph M. ;
Wexler, Ruth R. ;
Schumacher, William A. ;
Seiffert, Dietmar A. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (04) :416-423
[17]   A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits [J].
Wong, Pancras C. ;
Crain, Earl J. ;
Watson, Carol A. ;
Schumacher, William A. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (02) :129-137
[18]   Overview of the New Oral Anticoagulants Opportunities and Challenges [J].
Yeh, Calvin H. ;
Hogg, Kerstin ;
Weitz, Jeffrey I. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (05) :1056-1065